Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Aug;53(2):384-90.

Immunoregulation in glomerulonephritis, Henoch--Schonlein purpura and lupus nephritis

Immunoregulation in glomerulonephritis, Henoch--Schonlein purpura and lupus nephritis

K M Bannister et al. Clin Exp Immunol. 1983 Aug.

Abstract

Immunoregulation was examined in normal controls and in patients with immune complex glomerulonephritis and lupus nephritis (SLE) using OKT monoclonal anti-bodies against helper (OKT4) and suppressor (OKT8) T cell subsets. Functional studies assessed T cell control of in vitro immunoglobulin synthesis by cultured peripheral blood mononuclear cells (PBMC). IgG and IgA synthesis was measured in unstimulated, pokeweed mitogen (PWM) stimulated and PWM + concanavalin A (Con A) stimulated cultures. Patients with primary membranous nephropathy (MN) and mesangial IgA nephropathy (IgA GN) were found to have elevated T4/T8 ratios secondary to a deficiency of the T8+ subset. Patients with SLE had low T4/T8 ratios. B cell activation with high spontaneous immunoglobulin synthesis was present in cell cultures from patients with SLE, IgA GN and Henoch-Schonlein purpura (HSP). Defective Con A inducible suppression of in vitro immunoglobulin synthesis was found in SLE, HSP and to a lesser extent, primary MN. Functional Con A inducible suppressor defects correlated with elevated T4/T8 ratios only in patients with MN. All four disorders appear to share disturbances of cellular immune response with various degrees of defective immune suppression; however, it is not clear from these studies whether the defects are primary or secondary phenomena.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1977 Jan;59(1):106-16 - PubMed
    1. J Immunol. 1977 Jun;118(6):2004-8 - PubMed
    1. J Clin Invest. 1978 Oct;62(4):789-96 - PubMed
    1. J Immunol. 1978 Oct;121(4):1473-9 - PubMed
    1. Am J Med. 1978 Sep;65(3):437-45 - PubMed

Publication types

LinkOut - more resources